Assessment of Hepatic Arterial Infusion of Floxuridine With Systemic Gemcitabine and Oxaliplatin
This phase 2 clinical trial evaluates the use of hepatic arterial infusion of floxuridine plus systemic administration of gemcitabine and oxaliplatin in patients with unresectable intrahepatic cholangiocarcinoma.